Clinical Pharmacology and Drug Toxicity — MCQs
On this page
Which of the following is NOT characteristic of severe barbiturate poisoning?
Which of the following is NOT a common or well-known manifestation of an adverse drug reaction?
Which drug commonly causes impaired taste?
Epalrestat is a:
FK 506 is a type of:
Which immunosuppressant acts by inhibiting mTOR and is non-nephrotoxic?
A 65-year-old female with ovarian cancer is being treated with cisplatin-based chemotherapy. Which of the following is NOT used to limit the toxicity of cisplatin?
Which drug is known to cause a SLE-like syndrome?
Which of the following drugs is known to cause ototoxicity?
Alkalinization of urine is required to treat toxicity of all except:
Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs
Question 1: Which of the following is NOT characteristic of severe barbiturate poisoning?
- A. Hypothermia
- B. Hypertension (Correct Answer)
- C. Coma
- D. Non-reactive pupils
Explanation: **Explanation:** Severe barbiturate poisoning is characterized by generalized **Central Nervous System (CNS) and cardiovascular depression**. **1. Why Hypertension is the Correct Answer:** Barbiturates cause profound **hypotension**, not hypertension. This occurs due to a combination of direct myocardial depression, peripheral vasodilation (loss of vasomotor tone), and depression of the medullary vasomotor centers. In severe toxicity, this can lead to circulatory collapse and shock. **2. Analysis of Other Options:** * **Hypothermia (A):** Barbiturates depress the hypothalamic thermoregulatory center and reduce the metabolic rate, leading to a significant drop in body temperature. * **Coma (C):** As GABA-A receptor agonists, barbiturates increase the duration of chloride channel opening, leading to global CNS depression. This typically manifests as a deep, unresponsive coma. * **Non-reactive pupils (D):** While pupils may initially be constricted (miotic), in severe or terminal stages of barbiturate poisoning, hypoxic brain damage often results in paralytic dilatation and non-reactive pupils. **High-Yield Clinical Pearls for NEET-PG:** * **Respiratory Depression:** The most common cause of death in acute barbiturate poisoning is respiratory failure. * **Bullous Lesions:** The presence of **"Barbiturate blisters"** (clear vesicles/bullae) on pressure points is a characteristic, though not pathognomonic, skin finding. * **Management:** There is **no specific antidote**. Treatment is supportive (ABC). For long-acting barbiturates (e.g., Phenobarbital), **Urinary Alkalinization** with Sodium Bicarbonate is used to enhance excretion (ion trapping). Hemodialysis is reserved for extreme cases.
Question 2: Which of the following is NOT a common or well-known manifestation of an adverse drug reaction?
- A. Agranulocytosis
- B. Aplastic anaemia
- C. Haemolysis
- D. Leukaemia (Correct Answer)
Explanation: **Explanation:** In clinical pharmacology, **Adverse Drug Reactions (ADRs)** are typically categorized into predictable (Type A) and unpredictable/idiosyncratic (Type B) reactions. While many drugs can cause acute bone marrow suppression or blood dyscrasias, they rarely act as direct carcinogens to induce malignancy like **Leukaemia**. **Why Leukaemia is the correct answer:** Leukaemia is a neoplastic transformation of hematopoietic stem cells. While certain cytotoxic chemotherapy agents (like alkylating agents or etoposide) can cause "secondary leukaemia" years after treatment, it is considered a **long-term complication or secondary malignancy** rather than a common or classic manifestation of a standard ADR. In the context of competitive exams, blood dyscrasias (A, B, and C) are the hallmark examples of drug-induced hematotoxicity. **Analysis of incorrect options:** * **Agranulocytosis:** A classic idiosyncratic ADR. Common culprits include **Clozapine, Antithyroid drugs (Methimazole, PTU), and Dipyrone.** * **Aplastic Anaemia:** A life-threatening ADR characterized by pancytopenia. The most high-yield association is with **Chloramphenicol** (idiosyncratic type), but it is also seen with Phenylbutazone and Gold salts. * **Haemolysis:** A frequent ADR, especially in individuals with **G6PD deficiency** when exposed to oxidative drugs like **Primaquine, Sulfonamides, and Nitrofurantoin.** **High-Yield Clinical Pearls for NEET-PG:** * **Chloramphenicol** causes two types of bone marrow suppression: 1. Dose-dependent (reversible) and 2. Idiosyncratic aplastic anaemia (irreversible and fatal). * **Clozapine** monitoring requires mandatory weekly WBC counts due to the risk of agranulocytosis. * **Drug-induced SLE** is another common ADR question; remember **HIP** (Hydralazine, Isoniazid, Procainamide).
Question 3: Which drug commonly causes impaired taste?
- A. Metronidazole (Correct Answer)
- B. Losartan
- C. Paracetamol
- D. Aspirin
Explanation: **Explanation:** **Metronidazole** is a nitroimidazole antibiotic widely used for anaerobic bacterial and protozoal infections [1]. A classic, high-yield side effect of Metronidazole is a **metallic taste (dysgeusia)**. This occurs because the drug and its metabolites are secreted into the saliva, interacting directly with taste receptors. Patients should also be warned about the **disulfiram-like reaction** when consuming alcohol with this medication. **Analysis of Incorrect Options:** * **Losartan:** As an Angiotensin II Receptor Blocker (ARB), it is less likely to cause taste disturbances compared to ACE inhibitors (like Captopril), which are notorious for causing dysgeusia due to zinc chelation. * **Paracetamol (Acetaminophen):** Its primary toxicity is hepatotoxicity (centrilobular necrosis) mediated by the metabolite NAPQI. It does not typically affect taste. * **Aspirin:** The hallmark toxicity of aspirin (salicylism) includes tinnitus, vertigo, and respiratory alkalosis [2], but not impaired taste. **NEET-PG High-Yield Pearls:** * **Drugs causing Metallic Taste:** Metronidazole, Tinidazole, Clarithromycin, Lithium, Captopril, Carbonic anhydrase inhibitors (Acetazolamide), and Disulfiram [1]. * **Metronidazole Mnemonic (Side Effects):** **M**etallic taste, **E**ncephalopathy (rare), **T**oxicity with alcohol (Disulfiram-like), **R**eddish-brown urine (harmless metabolite). * **Clinical Note:** Always counsel patients on Metronidazole to avoid alcohol for at least 48–72 hours after the last dose to prevent severe vomiting and flushing.
Question 4: Epalrestat is a:
- A. Antihypertensive drug
- B. Antidiabetic drug
- C. Anti-tubercular drug
- D. None of the above (Correct Answer)
Explanation: **Explanation:** **Epalrestat** is a potent, reversible inhibitor of **aldose reductase**, an enzyme involved in the polyol pathway. While it is used in the management of complications arising from diabetes, it is pharmacologically classified as an **Aldose Reductase Inhibitor**, not an antidiabetic drug. 1. **Why "None of the above" is correct:** The polyol pathway becomes active during hyperglycemia; glucose is converted to sorbitol by aldose reductase. Accumulation of sorbitol leads to osmotic stress and oxidative damage, contributing to diabetic neuropathy. Epalrestat slows the progression of **diabetic peripheral neuropathy** and improves nerve conduction velocity. Since it does not lower blood glucose levels, it does not fit the definition of an "antidiabetic drug." 2. **Why other options are incorrect:** * **Antihypertensive drug:** These drugs (e.g., ACE inhibitors, Beta-blockers) act on the cardiovascular or renal systems to lower blood pressure. Epalrestat has no effect on systemic blood pressure. * **Antidiabetic drug:** These agents (e.g., Metformin, Insulin, Sulfonylureas) primarily aim to reduce blood glucose levels (HbA1c). Epalrestat manages a complication (neuropathy) but does not treat the underlying hyperglycemia. * **Anti-tubercular drug:** These are antibiotics (e.g., Isoniazid, Rifampicin) used to treat *Mycobacterium tuberculosis*. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Inhibits the conversion of Glucose → Sorbitol. * **Primary Indication:** Subjective symptoms of diabetic neuropathy (numbness, pain). * **Side Effects:** Elevation of liver enzymes (AST/ALT), nausea, and abdominal pain. * **Other Aldose Reductase Inhibitors:** Sorbinil, Ranirestat (mostly discontinued or under investigation due to toxicity).
Question 5: FK 506 is a type of:
- A. Immunoglobulin antibody
- B. Non-depolarizing muscle relaxant
- C. Macrolide antibiotic (Correct Answer)
- D. Opioid anaesthetic
Explanation: **Explanation:** **FK 506**, also known as **Tacrolimus**, is a potent immunosuppressant. Chemically, it is classified as a **macrolide antibiotic** (Option C) because it contains a large macrocyclic lactone ring in its structure. However, unlike erythromycin, it lacks significant antibacterial activity and is used primarily for its immunosuppressive properties. **Mechanism of Action:** Tacrolimus binds to an intracellular protein called **FK-binding protein (FKBP-12)**. This complex inhibits **calcineurin**, a phosphatase enzyme. Inhibition of calcineurin prevents the dephosphorylation of the Nuclear Factor of Activated T-cells (NFAT), thereby blocking the transcription of **Interleukin-2 (IL-2)** and other cytokines. This results in the inhibition of T-lymphocyte activation. **Analysis of Incorrect Options:** * **Option A:** It is a small molecule drug derived from the fungus *Streptomyces tsukubaensis*, not a protein-based immunoglobulin. * **Option B:** Non-depolarizing muscle relaxants (e.g., Vecuronium, Atracurium) act on nicotinic receptors at the neuromuscular junction; Tacrolimus has no such action. * **Option D:** Opioid anesthetics (e.g., Fentanyl) act on mu-opioid receptors for analgesia; Tacrolimus does not possess analgesic properties. **High-Yield Clinical Pearls for NEET-PG:** * **Indications:** Prophylaxis of organ transplant rejection (especially liver and kidney) and topically for atopic dermatitis. * **Potency:** Tacrolimus is **10–100 times more potent** than Cyclosporine. * **Side Effects:** Nephrotoxicity (most common), neurotoxicity (tremors, seizures), and **post-transplant diabetes mellitus (PTDM)**. Unlike Cyclosporine, it does *not* typically cause hirsutism or gum hyperplasia. * **Drug Interactions:** Metabolized by **CYP3A4**; levels increase with grapefruit juice or macrolide antibiotics (like Erythromycin).
Question 6: Which immunosuppressant acts by inhibiting mTOR and is non-nephrotoxic?
- A. Azathioprine
- B. Tacrolimus
- C. Sirolimus (Correct Answer)
- D. Rapamycin
Explanation: **Explanation:** **Sirolimus** (also known as **Rapamycin**) is the correct answer. It belongs to the class of drugs known as **mTOR inhibitors** (mammalian Target of Rapamycin). 1. **Mechanism of Action:** Sirolimus binds to the intracellular protein **FKBP-12**. This complex then inhibits the mTOR kinase, which is a key regulator of the cell cycle. By inhibiting mTOR, it prevents the progression of T-cells from the G1 to the S phase, thereby suppressing lymphocyte proliferation. 2. **Clinical Advantage:** Unlike Calcineurin inhibitors (CNIs), Sirolimus is notably **non-nephrotoxic**. This makes it an excellent alternative or adjunct in renal transplant patients to reduce the dose of nephrotoxic drugs. **Analysis of Incorrect Options:** * **Azathioprine:** An antimetabolite that acts as a prodrug for 6-mercaptopurine. It inhibits purine synthesis but does not involve the mTOR pathway. * **Tacrolimus:** A Calcineurin inhibitor (CNI). Like Sirolimus, it binds to FKBP-12, but the complex inhibits calcineurin, not mTOR. Crucially, Tacrolimus is **highly nephrotoxic**. * **Rapamycin:** While Rapamycin is the same chemical compound as Sirolimus, in the context of standardized exams like NEET-PG, if both names are provided, "Sirolimus" is the preferred pharmacological nomenclature. (Note: In most clinical scenarios, they are synonymous, but the question structure often tests the specific drug class name). **High-Yield NEET-PG Pearls:** * **Side Effects of Sirolimus:** While it spares the kidneys, it causes **Hyperlipidemia** (most common), thrombocytopenia, and impaired wound healing. * **Drug Interaction:** Both Tacrolimus and Sirolimus are metabolized by **CYP3A4**; grapefruit juice can increase their toxicity. * **Everolimus:** A newer mTOR inhibitor with a shorter half-life than Sirolimus.
Question 7: A 65-year-old female with ovarian cancer is being treated with cisplatin-based chemotherapy. Which of the following is NOT used to limit the toxicity of cisplatin?
- A. N-acetylcysteine (Correct Answer)
- B. Slow rate of infusion
- C. Chloride diuresis
- D. Amifostine
Explanation: ### Explanation **Cisplatin** is a potent platinum-based alkylating agent used for various solid tumors. Its dose-limiting toxicity is **nephrotoxicity** (specifically acute tubular necrosis), caused by the accumulation of the drug in the proximal convoluted tubules. **1. Why N-acetylcysteine (NAC) is the correct answer:** N-acetylcysteine is primarily used as an antidote for **Acetaminophen (Paracetamol) toxicity** (to replenish glutathione) and as a mucolytic. It has **no established clinical role** in preventing or limiting cisplatin-induced nephrotoxicity. While it is an antioxidant, it is not part of the standard protocol for cisplatin management. **2. Why the other options are incorrect (Methods to limit toxicity):** * **Slow rate of infusion:** Administering cisplatin slowly (over several hours) reduces the peak plasma concentration, thereby decreasing the immediate toxic impact on the renal tubules. * **Chloride diuresis:** Cisplatin is more stable and less reactive in high-chloride environments. Aggressive pre- and post-treatment hydration with **Normal Saline (0.9% NaCl)** maintains high chloride levels in the renal tubules, preventing the conversion of cisplatin into its toxic aquated form. * **Amifostine:** This is a cytoprotective adjuvant. It is a prodrug that is converted by alkaline phosphatase into a free thiol, which scavenges reactive metabolites of cisplatin specifically in normal tissues, reducing nephrotoxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Cisplatin Toxicities:** "3 N's" — **N**ephrotoxicity, **N**eurotoxicity (peripheral neuropathy), and **N**ausea/Vomiting (highly emetogenic). * **Ototoxicity:** Cisplatin also causes high-frequency hearing loss (tinnitus/deafness). * **Drug of Choice for Cisplatin-induced Emesis:** Palonosetron (5-HT3 antagonist) + Dexamethasone + Aprepitant (NK1 antagonist). * **Amifostine** is also used to reduce xerostomia (dry mouth) in patients undergoing radiotherapy.
Question 8: Which drug is known to cause a SLE-like syndrome?
- A. Hydralazine
- B. Phenytoin
- C. Procainamide
- D. All of the above (Correct Answer)
Explanation: **Explanation:** Drug-Induced Lupus Erythematosus (DILE) is a syndrome clinically similar to systemic lupus erythematosus (SLE) but triggered by long-term exposure to certain medications. The underlying mechanism typically involves the drug acting as a hapten or interfering with DNA methylation, leading to the formation of **Antihistone antibodies**, which are the hallmark of this condition (present in >90% of cases). * **Hydralazine:** An arterial vasodilator used in hypertension. It is one of the most common causes of DILE, particularly in "slow acetylators" (individuals with a genetic deficiency in the N-acetyltransferase enzyme). * **Procainamide:** A Class IA anti-arrhythmic. It has the highest risk/incidence of inducing DILE; nearly 20% of patients develop clinical symptoms, and up to 80% develop ANA positivity. * **Phenytoin:** An anti-epileptic drug that can trigger lupus-like symptoms, though less frequently than the drugs mentioned above. Since all three drugs are well-documented triggers for this syndrome, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** 1. **Key Marker:** Antihistone antibodies are highly specific for DILE, whereas anti-dsDNA antibodies (common in idiopathic SLE) are usually absent. 2. **Clinical Presentation:** Patients typically present with pleuritis, pericarditis, fever, and arthralgia. Notably, **renal and CNS involvement are rare** in DILE compared to idiopathic SLE. 3. **Management:** Symptoms usually resolve spontaneously within weeks after discontinuing the offending drug. 4. **Mnemonic (SHIPP):** **S**ulfonamides, **H**ydralazine, **I**soniazid, **P**henytoin, **P**rocainamide. (Other culprits include Minocycline and Anti-TNF drugs).
Question 9: Which of the following drugs is known to cause ototoxicity?
- A. Vancomycin
- B. Streptomycin (Correct Answer)
- C. Ampicillin
- D. Rifampicin
Explanation: **Explanation:** **Streptomycin** is the correct answer because it belongs to the **Aminoglycoside** class of antibiotics, which are notorious for their dose-dependent and duration-dependent **ototoxicity** [2], [3]. Aminoglycosides accumulate in the perilymph and endolymph of the inner ear, leading to the destruction of sensory hair cells [1], [3]. Streptomycin, specifically, is more **vestibulotoxic** (causing vertigo, ataxia, and loss of balance) than cochleotoxic [2], [4], though it can cause permanent hearing loss. **Analysis of Incorrect Options:** * **Vancomycin (Option A):** While often cited in older literature as ototoxic, modern purified preparations of Vancomycin rarely cause ototoxicity when used alone. It typically only increases the risk of hearing loss when administered concurrently with other ototoxic drugs (like aminoglycosides or loop diuretics). * **Ampicillin (Option C):** This is a penicillin-group antibiotic. Its primary adverse effects are hypersensitivity reactions (rashes, anaphylaxis) and diarrhea; it has no known association with ototoxicity. * **Rifampicin (Option D):** An anti-tubercular drug primarily known for causing orange-red discoloration of body fluids (urine, sweat, tears) and hepatotoxicity. It does not affect the auditory or vestibular systems. **High-Yield Clinical Pearls for NEET-PG:** * **Aminoglycoside Mnemonic:** Remember that **S**treptomycin and **G**entamicin are primarily **Vestibulotoxic**, while **A**mikacin, **K**anamycin, and **N**eomycin are primarily **Cochleotoxic** [4]. * **Synergy:** The risk of ototoxicity increases significantly when aminoglycosides are combined with **Loop Diuretics** (e.g., Furosemide, Ethacrynic acid). * **Genetic Predisposition:** Patients with the **m.1555A>G mutation** in mitochondrial DNA are at a significantly higher risk of permanent aminoglycoside-induced deafness, even with a single dose.
Question 10: Alkalinization of urine is required to treat toxicity of all except:
- A. Salicylates
- B. Barbiturates
- C. Amphetamine (Correct Answer)
- D. Methotrexate
Explanation: ### Explanation The principle underlying this question is **Ion Trapping**, which is based on the **Henderson-Hasselbalch equation**. To enhance the renal excretion of a drug, the urine pH must be adjusted to ensure the drug remains in its **ionized (charged) form**, preventing its reabsorption across the renal tubular membrane. **1. Why Amphetamine is the Correct Answer:** Amphetamine is a **weak base**. According to the principle of ion trapping, weak bases are ionized in an **acidic environment**. Therefore, to treat amphetamine toxicity, **acidification of urine** (using Ammonium Chloride) is required to trap the drug in the renal tubules and promote excretion. Alkalinization would keep a weak base in its non-ionized form, increasing its reabsorption. **2. Why the other options are incorrect:** * **Salicylates (A) and Barbiturates (B):** These are **weakly acidic** drugs. Alkalinization of urine (using Sodium Bicarbonate) converts them into their ionized (salt) form, trapping them in the urine and accelerating clearance. This is a standard treatment for Aspirin and Phenobarbital overdose. * **Methotrexate (D):** Methotrexate is also an acidic drug. Alkalinization is crucial here not only to increase excretion but also to **prevent crystalluria** and subsequent acute kidney injury, as methotrexate is more soluble in alkaline urine. ### NEET-PG High-Yield Pearls: * **Alkalinization of Urine:** Used for **Acidic drugs** (Salicylates, Barbiturates, Methotrexate, Sulfonamides, Fluoride). Target urine pH is usually 7.5–8.5. * **Acidification of Urine:** Used for **Basic drugs** (Amphetamines, Phencyclidine, Quinine). *Note: Clinically, acidification is rarely performed now due to the risk of metabolic acidosis and worsening rhabdomyolysis.* * **Forced Alkaline Diuresis:** Involves the administration of IV fluids + Sodium Bicarbonate + Loop diuretics (like Furosemide).
Practice by Chapter
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free